Tonsillectomy is one of the most common—and painful—pediatric surgeries in the US, with around 500,000 cases performed each year. Despite standard pain management with acetaminophen and ibuprofen, at least 10% of kids still need opioids, and post-op pain can rival the intensity reported after kidney transplants or hysterectomies. A new placebo-controlled RCT published in JAMA Otolaryngology–Head & Neck Surgery suggests a simple, inexpensive fix may help.

The trial of 209 children (ages 3–17) found that oral dexamethasone given on postoperative days 2, 4, and 6 modestly reduced pain scores and—more notably—substantially lowered the odds of opioid prescriptions and emergency department visits for pain. No increase in complications was observed in the treatment group. Researchers noted the greatest benefit in children aged 8–12, and benefits extended through days 12–14, suggesting early inflammation control supports a smoother recovery.

Key Takeaways:

• Dexamethasone group had mean pain scores 0.72 points lower than placebo (4.12 vs. 4.84) on days 2–8
• Odds of receiving an opioid prescription were 77% lower (OR 0.23) in the dexamethasone group
• Odds of an ED visit for pain were 88% lower (OR 0.12) in the dexamethasone group

Why it matters: Even modest pain reductions appear sufficient to keep kids out of the ER and off opioids—a meaningful outcome for families and the healthcare system alike. Some ENT specialists are already using this approach, and the study adds solid evidence to support broader adoption.